Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.

Michelson D, Lydiard RB, Pollack MH, Tamura RN, Hoog SL, Tepner R, Demitrack MA, Tollefson GD.

Am J Psychiatry. 1998 Nov;155(11):1570-7. Erratum in: Am J Psychiatry 1999 Jan;156(1):161.

PMID:
9812120
2.

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.

Lepola UM, Wade AG, Leinonen EV, Koponen HJ, Frazer J, Sjödin I, Penttinen JT, Pedersen T, Lehto HJ.

J Clin Psychiatry. 1998 Oct;59(10):528-34.

PMID:
9818634
3.

Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group.

Michelson D, Pollack M, Lydiard RB, Tamura R, Tepner R, Tollefson G.

Br J Psychiatry. 1999 Mar;174:213-8.

PMID:
10448445
4.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
5.

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.

Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP.

Am J Psychiatry. 1998 Jan;155(1):36-42.

PMID:
9433336
7.

Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.

Judd LL, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, Kupfer DJ, Plewes JM, Schettler PJ, Tollefson G.

Am J Psychiatry. 2004 Oct;161(10):1864-71.

PMID:
15465984
8.
9.

Panic disorder: treatment with valproate.

Woodman CL, Noyes R Jr.

J Clin Psychiatry. 1994 Apr;55(4):134-6.

PMID:
8071256
10.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
11.

An open-label trial of nefazodone in high comorbidity panic disorder.

DeMartinis NA, Schweizer E, Rickels K.

J Clin Psychiatry. 1996 Jun;57(6):245-8.

PMID:
8666561
12.

A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study.

Prosser JM, Yard S, Steele A, Cohen LJ, Galynker II.

BMC Psychiatry. 2009 May 26;9:25. doi: 10.1186/1471-244X-9-25.

13.

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

Sheehan DV, Burnham DB, Iyengar MK, Perera P; Paxil CR Panic Disorder Study Group.

J Clin Psychiatry. 2005 Jan;66(1):34-40.

PMID:
15669886
14.

Sertraline treatment of panic disorder: response in patients at risk for poor outcome.

Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.

J Clin Psychiatry. 2000 Dec;61(12):922-7.

PMID:
11206597
15.

Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.

Pollack MH, Rapaport MH, Fayyad R, Otto MW, Nierenberg AA, Clary CM.

J Psychiatr Res. 2002 Jul-Aug;36(4):229-36.

PMID:
12191627
17.

Open prospective trial of fluoxetine for posttraumatic stress disorder.

Nagy LM, Morgan CA 3rd, Southwick SM, Charney DS.

J Clin Psychopharmacol. 1993 Apr;13(2):107-13.

PMID:
8463442
18.

Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.

Greenblatt DJ, Harmatz JS, Shader RI.

Arch Gen Psychiatry. 1993 Sep;50(9):715-22.

PMID:
8357297
19.

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R.

Arch Gen Psychiatry. 1998 Nov;55(11):1010-6.

PMID:
9819070
20.

Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.

Schweizer E, Patterson W, Rickels K, Rosenthal M.

Am J Psychiatry. 1993 Aug;150(8):1210-5.

PMID:
8328566

Supplemental Content

Support Center